This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Avvinity Therapeutics Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Bradley Hall
Introduction
Bradley Hall is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. His work focuses on aptamers, which are short, single-stranded nucleic acids that can bind to specific targets, such as proteins.
Latest Patents
Bradley Hall holds a patent for "Aptamers against EGFR and therapeutic uses thereof." This invention relates to novel aptamers capable of binding to the epidermal growth factor receptor (EGFR). The patent also covers cancer cell binding complexes that utilize these aptamers, highlighting their potential use in cancer treatment.
Career Highlights
Bradley Hall is associated with Avvinity Therapeutics Limited, a company dedicated to advancing therapeutic solutions through innovative research. His work at the company emphasizes the importance of aptamers in medical applications, particularly in oncology.
Collaborations
Bradley collaborates with Paul Hatala, contributing to the advancement of their shared research goals. Their partnership enhances the development of effective therapeutic strategies in the field of cancer treatment.
Conclusion
Bradley Hall's innovative work in the field of aptamers showcases his commitment to advancing cancer therapies. His contributions are paving the way for new treatment options that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile